THE ENDOTHELIAL L-ARGININE NITRIC-OXIDE PATHWAY AND THE RENAL CIRCULATION

被引:27
|
作者
LUSCHER, TF [1 ]
BOCK, HA [1 ]
机构
[1] UNIV BASEL KLINIKEN, KANTONSPITAL, DEPT MED, BASEL, SWITZERLAND
来源
KLINISCHE WOCHENSCHRIFT | 1991年 / 69卷 / 13期
关键词
CYCLIC GMP; ENDOTHELIUM-DERIVED RELAXING FACTOR; KIDNEY DISEASE; PLATELETS; VASODILATATION;
D O I
10.1007/BF01649323
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial cells contain an enzyme(s) which produces nitric oxide from L-arginine in response to a variety of mechanical stimuli as well as to autacoids and local and circulating hormones. Nitric oxide is a potent vasodilator and inhibitor of platelet function; it exerts its effects via activation of soluble guanylate cyclase and subsequent formation of cyclic 3'-5'-guanosine monophosphate. In the kidney, activation of the endothelial L-arginine pathway is associated with increases in renal blood flow, diuresis and natriuresis, while the glomerular filtration rate remains constant. The activity of the endothelial L-arginine pathway is impaired in hypertension and during chronic therapy with cyclosporine A. In addition, diabetes and atherosclerosis impair this pathway. Thus, the endothelial L-arginine pathway plays an important role in the local regulation of blood flow. Alterations in the activity of this pathway may play an important role in the pathophysiology of hypertension and renal disease.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 50 条
  • [1] THE L-ARGININE - NITRIC-OXIDE PATHWAY
    MONCADA, S
    HIGGS, EA
    HODSON, HF
    KNOWLES, RG
    LOPEZJARAMILLO, P
    MCCALL, T
    PALMER, RMJ
    RADOMSKI, MW
    REES, DD
    SCHULZ, R
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S1 - S9
  • [2] THE L-ARGININE - NITRIC-OXIDE PATHWAY
    MONCADA, S
    ACTA PHYSIOLOGICA SCANDINAVICA, 1992, 145 (03): : 201 - 227
  • [3] ROLE OF L-ARGININE NITRIC-OXIDE PATHWAY IN HYPERTENSION
    HISHIKAWA, K
    NAKAKI, T
    SUZUKI, H
    KATO, R
    SARUTA, T
    JOURNAL OF HYPERTENSION, 1993, 11 (06) : 639 - 645
  • [4] MECHANISMS OF DISEASE - THE L-ARGININE NITRIC-OXIDE PATHWAY
    MONCADA, S
    HIGGS, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27): : 2002 - 2012
  • [5] MANIPULATION OF THE L-ARGININE NITRIC-OXIDE PATHWAY IN EXPERIMENTAL COLITIS
    NEILLY, PJD
    KIRK, SJ
    GARDINER, KR
    ANDERSON, NH
    ROWLANDS, BJ
    BRITISH JOURNAL OF SURGERY, 1995, 82 (09) : 1188 - 1191
  • [6] AMELIORATION BY L-ARGININE OF A DYSFUNCTIONAL ARGININE NITRIC-OXIDE PATHWAY IN DIABETIC ENDOTHELIUM
    PIEPER, GM
    PELTIER, BA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (03) : 397 - 403
  • [7] MODULATION OF PLATELET-AGGREGATION BY AN L-ARGININE NITRIC-OXIDE PATHWAY
    RADOMSKI, MW
    PALMER, RMJ
    MONCADA, S
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (03) : 87 - 88
  • [8] PRECONDITIONING OF THE ISCHEMIC MYOCARDIUM - INVOLVEMENT OF THE L-ARGININE NITRIC-OXIDE PATHWAY
    VEGH, A
    SZEKERES, L
    PARRATT, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) : 648 - 652
  • [9] THE L-ARGININE NITRIC-OXIDE PATHWAY IN THE RABBIT URETHRAL LAMINA PROPRIA
    ZYGMUNT, PKE
    PERSSON, K
    ALM, P
    LARSSON, B
    ANDERSSON, KE
    ACTA PHYSIOLOGICA SCANDINAVICA, 1993, 148 (04): : 431 - 439
  • [10] L-ARGININE - NITRIC-OXIDE PATHWAY IN ENDOTOXEMIA AND HUMAN SEPTIC SHOCK
    GOMEZJIMENEZ, J
    SALGADO, A
    MOURELLE, M
    MARTIN, MC
    SEGURA, RM
    PERACAULA, R
    MONCADA, S
    CRITICAL CARE MEDICINE, 1995, 23 (02) : 253 - 258